Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic.
Walsh SL, Eissenberg T. Walsh SL, et al. Among authors: eissenberg t. Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S13-27. doi: 10.1016/s0376-8716(03)00056-5. Drug Alcohol Depend. 2003. PMID: 12738347 Review.
Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML. Eissenberg T, et al. J Pharmacol Exp Ther. 1996 Feb;276(2):449-59. J Pharmacol Exp Ther. 1996. PMID: 8632309
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.
Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. Johnson RE, et al. Among authors: eissenberg t. Drug Alcohol Depend. 1995 Nov;40(1):17-25. doi: 10.1016/0376-8716(95)01186-2. Drug Alcohol Depend. 1995. PMID: 8746920 Clinical Trial.
Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.
Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. Johnson RE, et al. Among authors: eissenberg t. Drug Alcohol Depend. 1995 Nov;40(1):27-35. doi: 10.1016/0376-8716(95)01189-7. Drug Alcohol Depend. 1995. PMID: 8746921 Clinical Trial.
Human drug discrimination and multiple chemical sensitivity: caffeine exposure as an experimental model.
Eissenberg T, Griffiths RR. Eissenberg T, et al. Environ Health Perspect. 1997 Mar;105 Suppl 2(Suppl 2):509-13. doi: 10.1289/ehp.97105s2509. Environ Health Perspect. 1997. PMID: 9167988 Free PMC article. Review.
Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients.
Eissenberg T, Johnson RE, Bigelow GE, Walsh SL, Liebson IA, Strain EC, Stitzer ML. Eissenberg T, et al. Drug Alcohol Depend. 1997 Apr 14;45(1-2):81-91. doi: 10.1016/s0376-8716(97)01347-1. Drug Alcohol Depend. 1997. PMID: 9179510 Clinical Trial.
Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. A randomized clinical trial.
Eissenberg T, Bigelow GE, Strain EC, Walsh SL, Brooner RK, Stitzer ML, Johnson RE. Eissenberg T, et al. JAMA. 1997 Jun 25;277(24):1945-51. JAMA. 1997. PMID: 9200635 Clinical Trial.
Induction with levomethadyl acetate: safety and efficacy.
Jones HE, Strain EC, Bigelow GE, Walsh SL, Stitzer ML, Eissenberg T, Johnson RE. Jones HE, et al. Among authors: eissenberg t. Arch Gen Psychiatry. 1998 Aug;55(8):729-36. doi: 10.1001/archpsyc.55.8.729. Arch Gen Psychiatry. 1998. PMID: 9707384 Clinical Trial.
Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
Eissenberg T, Stitzer ML, Bigelow GE, Buchhalter AR, Walsh SL. Eissenberg T, et al. J Pharmacol Exp Ther. 1999 May;289(2):936-45. J Pharmacol Exp Ther. 1999. PMID: 10215673 Clinical Trial.
High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML. Donny EC, et al. Among authors: eissenberg t. Psychopharmacology (Berl). 2002 May;161(2):202-12. doi: 10.1007/s00213-002-1027-0. Epub 2002 Mar 13. Psychopharmacology (Berl). 2002. PMID: 11981600
258 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback